Promising Developments in Arbutus Biopharma’s Pipeline Lead to Buy Rating and Increased Price Target
Keay Nakae, an analyst from Chardan Capital, maintained the Buy rating on Arbutus Biopharma (ABUS – Research Report). The associated ...
mitsloanreview32m
Latino Voters Have Options: That’s a Good Thing
Joe Biden was always intended to be a someone who could get Trump out of office, and who would then pass the torch to a new generation of Democrats.